Press Release THE MARK HOTEL CELEBRATED IN THE WORLD'S 50 BEST HOTELS 2025 PRESTIGIOUS RANKING Celebrating innovation, excellence, and transformative travel experiences worldwide NEW YORK, Oct. 31,… CISION PRNewswireOctober 31, 2025
China, United States can achieve mutual success, shared prosperity BEIJING, Oct. 31, 2025 /PRNewswire/ — A report from People’s Daily: On… CISION PRNewswireOctober 31, 2025
Visionary Holdings Inc. 2025 Annual General Meeting Concludes Successfully: Completes Board Renewal, Anchors New Direction for Compliant Development TORONTO, Oct. 31, 2025 /PRNewswire/ — Visionary Holdings Inc. (hereinafter referred to as… CISION PRNewswireOctober 31, 2025
JoyLogistics Launches Integrated Delivery and Installation Service for Bulky Items in Malaysia and Singapore SINGAPORE, Oct. 31, 2025 /PRNewswire/ — JoyLogistics, the supply chain solutions arm… CISION PRNewswireOctober 31, 2025
Press Release Abu Dhabi Royal Equestrian Arts, the World's Fifth School of Classical Horsemanship, Officially Opens Its Doors ABU DHABI, UAE, Oct. 31, 2025 /PRNewswire/ — In a landmark moment… CISION PRNewswireOctober 31, 2025
Press Release NAVEE Launches XT5 Pro All-Terrain Electric Scooter, Expanding Green Mobility Beyond the City EL MONTE, Calif., Oct. 31, 2025 /PRNewswire/ — NAVEE, a leading innovator… CISION PRNewswireOctober 31, 2025
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. SHANGHAI, Oct. 31, 2025 /PRNewswire/ — Shanghai Zhimeng Biopharma Inc. ( "Zhimeng")… CISION PRNewswireOctober 31, 2025
NYSE Content Advisory: Pre-Market Update + Emera Celebrates NYSE Listing NEW YORK, Oct. 31, 2025 /PRNewswire/ — The New York Stock Exchange… CISION PRNewswireOctober 31, 2025
